Artículos del autor

solaci

Acute coronary syndromes

Zwolle Score: Can a Risk Score Decide Where STEACS Patients Should Stay?

The mortality of ST-segment elevation acute coronary syndromes (STEACS) has decreased thanks to improved reperfusion times (fibrinolysis...
solaci -
Institutional News

Sorrow for the Loss of Dr. Sousa

On behalf of the Latin American Society of Interventional Cardiology (SOLACI), We extend our deepest condolences for...
solaci -
Institutional News

ST Elevation Acute Myocardial Infarction Management in Latin America: A Survey

We are glad to invite the entire Latin American community to make part of this survey aimed...
solaci -
Structural heart disease

Is Cusp Overlapping Projection the New Self-Expandable Valve Implantation Technique?

In Europe and the US, aortic stenosis is the most frequent cause of valve intervention, both surgical...
solaci -
Institutional News

17/03 | SOLACI-TERUMO Webinar: Latest Evidence on Treatment of HBR Patients: Balancing Bleeding and Ischemic Risk

We invite the entire Latin American community to participate in our next virtual event that we will...
solaci -
Mitral valve

MitraClip Failure: What Should We Do?

Currently, edge-to-edge therapy with MitraClip has demonstrated efficacy and safety for the treatment of patients with degenerative...
solaci -
Institutional News

Rewatch our Webinar on Conquering Complex Coronary Lesions on our Youtube channel

Rewatch our Webinar on Conquering Complex Coronary Lesions on our Youtube channel. See it below! Conquering Complex Coronary Lesions
solaci -
Acute coronary syndromes

Is Epinephrine Superior to Adenosine in No-REFLOW?

In patients with acute coronary syndrome, no-reflow prevalence is 32%. Different drugs—such as adenosine, verapamil, nitroprusside, or...
solaci -